Host innate immune response

**The host innate immune response** is the body's first line of defense against invading pathogens, acting rapidly and non-specifically through several interconnected mechanisms[1][2][3][4][5]. Key components include physical and chemical barriers (such as skin, mucosa, and antimicrobial secretions), innate immune cells (including macrophages, neutrophils, dendritic cells, mast cells, and natural killer cells), and pattern recognition receptors (such as Toll-like receptors, NOD-like receptors, and RIG-I-like receptors)[1][3][4]. These receptors recognize broadly conserved pathogen-associated molecules absent in the host, triggering inflammatory and microbicidal responses. The innate system also interfaces closely with the adaptive immune system by presenting antigens and producing cytokines that help initiate the adaptive response[1][2][3][4][5]. Dysregulation or genetic deficiency in innate immunity can predispose to infection, inflammatory conditions, and immune deficiency syndromes[4]. The innate immune response itself is not a drug target or receptor; rather, individual components—such as Toll-like receptor 4 or Type I interferon—may themselves be considered drug targets. Because "Host innate immune response" is a process, not a discrete molecule, it is not a canonical drug target, and is_incorrect is set to true. For structured data on drug targets, individual components (like "Toll-like receptor 4", "Interleukin-1 receptor", "NOD2", etc.) should be used instead[1][2][3][4][5].

Other names

Innate immunityInnate immune systemNonspecific immune systemNatural immunity